Magic mushroom drug tested as potential breakthrough for opioid crisis
NCT ID NCT06786325
Summary
This study is testing whether a single dose of psilocybin, the active compound in 'magic mushrooms,' can help people with opioid addiction. Researchers will give 36 people in treatment either a 25mg dose or a very low 1mg dose to see if the higher dose improves their ability to think flexibly, reduces their opioid use, and helps them stick with their medication-assisted treatment. The study will track participants for a year to see if the treatment has lasting benefits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.